Our DATA for LIFE® mantra celebrates Pyxant Labs’ participation in an industry which saves lives. We fulfill an essential role in the drug development process. We have developed seminal capabilities directly supporting a cure for hepatitis, antiviral therapeutics for HIV, a fundamental understanding of Alzheimer’s Disease, antisense therapeutics, and now therapeutics for COVID-19. Founded in 2000, Pyxant Labs is a leading North American bioanalytical contract research organization, proud to call Colorado Springs and Salt Lake City its home. We provide bioanalysis to pharmaceutical companies for all stages of the drug development process. Using advanced sample preparation techniques and the latest mass spectrometry capabilities, Pyxant Labs develops and validates bioanalytical assay methods to FDA and international regulatory requirements. Our durable and reliable assays eliminate rework, minimize regulatory challenges, and reduce time to new drug application approval. With our scientists and program managers’ average bioanalysis experience exceeding 20 years, our industry-leading performance derives from experience spanning 1,000,000 sample assays, 800 FDA studies, six successful FDA audits, and 125 client regulatory audits.